NCT00618267 ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay. Status COMPLETED Phase N/A
NCT00617383 AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS Status COMPLETED Phase N/A
NCT00616733 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients Status COMPLETED Phase PHASE1
NCT00612872 Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects Status TERMINATED Phase PHASE1
NCT00607126 Locomotor Training in Persons With Multiple Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT00605215 BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) Status COMPLETED Phase PHASE3
NCT00599274 Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis Status COMPLETED Phase N/A
NCT00591721 Teleconference Fatigue Management for People With Multiple Sclerosis Status COMPLETED Phase NA
NCT00548769 Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients Status COMPLETED Phase PHASE1
NCT00537082 Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS) Status COMPLETED Phase PHASE2
NCT00536120 The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00529581 A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00513448 Promoting Physical Activity for Persons With Multiple Sclerosis Status COMPLETED Phase NA
NCT00510523 Whole Body Vibration Therapy in Participants With MS Related Balance Deficits Status COMPLETED Phase NA
NCT00509145 Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) Status COMPLETED Phase PHASE3